Kaplan Fox & Kilsheimer LLP Encourages Investors of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) to Contact the Firm Regarding Potential Securities Law Violations
Kaplan Fox is investigating potential securities law violations by Madrigal Pharmaceuticals (NASDAQ: MDGL) after its stock fell on Nov. 3, 2026.
Short extract only — this publisher licenses its text. Read the full release at the source.
Free plan · Plus CA$29 or Pro CA$99/month


